Science to practice: Can we expand focal interventional oncologic ablation treatments into an effective systemic therapy?

Radiology

Volumn 267, Issue 2, 2013, Pages 321-323

  Goldberg, S Nahum ^a,b  

^a HADASSAH HEBREW UNIVERSITY MEDICAL CENTER   (Israel)

^b Section of Interventional Radiology   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

PICIBANIL;

ARTICLE; CANCER COMBINATION CHEMOTHERAPY; CANCER INHIBITION; CANCER SURVIVAL; CLINICAL EFFECTIVENESS; CLINICAL PRACTICE; EAR TUMOR; GROWTH INHIBITION; IMMUNOMODULATION; IMMUNOSTIMULATION; INTERVENTION STUDY; LUNG TUMOR; NONHUMAN; PRIORITY JOURNAL; RADIOFREQUENCY ABLATION; SYSTEMIC THERAPY; TUMOR IMMUNITY; TUMOR REGRESSION; TUMOR VOLUME;

ANIMALS; CATHETER ABLATION; LUNG NEOPLASMS; PICIBANIL;

EID: 84876921387     PISSN: 00338419     EISSN: 15271315     Source Type: Journal    
DOI: 10.1148/radiol.13130140     Document Type: Article

References (11)

1. Hamamoto S, Okuma T, Yamamoto A, et al. Radiofrequency ablation and immunostimulant OK-432: combination therapy enhances systemic antitumor immunity for treatment of VX2 lung tumors in rabbits. Radiology 2013;267(2):405-413.
2. Ahmed M, Brace CL, Lee FT Jr., Goldberg SN. Principles of and advances in percutaneous ablation. Radiology 2011;258(2):351-369.
3. Nijkamp MW, Borren A, Govaert KM, et al. Radiofrequency ablation of colorectal liver metastases induces an inflammatory response in distant hepatic metastases but not in local accelerated outgrowth. J Surg Oncol 2010;101(7):551-556.
4. Haen SP, Pereira PL, Salih HR, Rammensee HG, Gouttefangeas C. More than just tumor destruction: immunomodulation by thermal ablation of cancer. Clin Dev Immunol 2011; 2011:160-250.
5. Goldberg SN. Mechanisms matter. J Vasc Interv Radiol 2012;23(1):114-115.
6. Chen WL, Huang ZQ, Zhang DM, Chai Q. Percutaneous sclerotherapy of massive venous malformations of the face and neck using fibrin glue combined with OK-432 and pingyangmycin. Head Neck 2010;32(4):467-472.
7. Waitz R, Solomon SB. Can local radiofrequency ablation of tumors generate systemic immunity against metastatic disease? Radiology 2009;251(1):1-2.
8. Dromi SA, Walsh MP, Herby S, et al. Radiofrequency ablation induces antigen-presenting cell infiltration and amplification of weak tumor-induced immunity. Radiology 2009; 251(1):58-66.
9. Saito K, Araki K, Reddy N, Guang W, O'Malley BW Jr., Li D. Enhanced local dendritic cell activity and tumor-specific immunoresponse in combined radiofrequency ablation and interleukin-2 for the treatment of human head and neck cancer in a murine orthotopic model. Head Neck 2011;33(3):359-367.
10. Wissniowski TT, Hänsler J, Neureiter D, et al. Activation of tumor-specific T lymphocytes by radio-frequency ablation of the VX2 hepatoma in rabbits. Cancer Res 2003;63(19): 6496-6500.
11. Ahmad F, Gravante G, Bhardwaj N, et al. Changes in interleukin-1b and 6 after hepatic microwave tissue ablation compared with radiofrequency, cryotherapy and surgical resections. Am J Surg 2010;200(4):500-506.